Home
Search
Events

BIO Asia International Conference

March 9-10, 2021・Grand Hyatt Tokyo, Japan
Accelerate your Pathway to Partnerships in Asia.

About the BIO Asia International Conference

The BIO Asia International Conference in Tokyo brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market and throughout the region.  Companies with more than 460 therapeutic assets from more than 25 countries pursued Partnering discussions at the 2019 Tokyo conference.

#BIOASIA19 At a Glance
1,270
+
BIO One-on-One Partnering Meetings
50
Presenting Companies
27
Participating Countries

Assets by Therapeutic Area

  Therapeutic Area
Neoplasm
Inflammatory disease
Immune disorder
Neurological disease
Gastrointestinal disease
Respiratory disease
Musculoskeletal disease
Psychiatric disorder
Hematological disease
Dermatological disease
Ocular disease
Cardiovascular disease
Infectious disease
Gynecology and obstetrics
Degeneration
Other		 Assets
107
97
69
58
50
47
33
28
25
22
22
21
19
12
10
49		 Increase Since Last Update
+6
+4
+3
+7
+3
+1
+1
0
+2
+4
+3
+1
0
+2
0
+5

*as of February 14, 2020

View All Partnering Companies

 

Participating Investors

Meet the venture capital and private equity investors focused on cross-border biotechnology development who are currently active in the partnering system and ready to meet.
Aceras Life Sciences | Asset Management Ventures | BioInnovation Capital | Chaperone Investment | Eight Roads Ventures |  Japan First Republic Bank | Hannol Ventures | Harbin Pharma | JAFCO Mitsubishi UFJ Capital | Mitsui Global Investment |  Momentum Biotech | MSQ Ventures | Otsuka Pharmacautical Co. | Premir Partners | Shinsei Capital Partners | W Global Capital

View Partnering Companies
EVT-ASIA20_Partnering
Top Blog Posts
Globe
Head of Japan’s Drug Regulatory Authority Will Keynote BIO Asia
BY George Goodno
POSTED ON
March 4, 2019
fight-covid-19-bio.png
New Drug Pricing Executive Order is “Reckless” And “Dumbfounding”
BY Jacy Gomez
POSTED ON
September 16, 2020
Biotech Leaders: Trust Science to Eradicate Covid-19
Biotech Leaders: Trust Science to Eradicate Covid-19
BY Jacy Gomez
POSTED ON
September 9, 2020
Subscribe to BIO Asia

Subscribe to BIO Asia International Conference and receive timely event updates, exclusive content, partnering and programming announcements, and more.

Add Me to the Mailing List
Thank You to Our 2020 Sponsors
View All Sponsors